RECRUITING

Glucose Variability and Cognition in Prediabetes

Talk to us

Conditions

Glucose Metabolism Disorders (Including Diabetes Mellitus)Cognitive DeclineFunctional StatusPreDiabetesAgingDepressionGlucose VariabilityContinuous Glucose Monitoring System (CGMS)Physical FunctioningNeurocognition

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.

Official Title

Relations of Glucose Variability With Cognitive Function and Functional Status Among Older Adults at Risk for Diabetes

Quick Facts

Study Start:2022-03-01
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04201600

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Aged 50 years and older
  2. * At least 8th grade education
  1. * Diagnosed type 1 or type 2 diabetes
  2. * Current use of mediation for diabetes (oral hypoglycemic agents, insulin), or with diabetic properties (e.g., steroids)
  3. * Chronic disorders (cardiovascular disease, peripheral vascular disease, stroke, transient ischemic attack, chronic kidney disease, past year cancer)
  4. * Neurological disorders (e.g., Parkinson's, epilepsy, multiple sclerosis)
  5. * History of dementia or suspected dementia
  6. * Known HIV
  7. * Serious mental illness, psychosis, or use of psychotropic medication
  8. * Heavy alcohol use

Contacts and Locations

Study Contact

Kathleen Simpson
CONTACT
4106057179
Kathleen.Simpson@va.gov
Ashley Splain, BA
CONTACT
asplain1@umbc.edu

Principal Investigator

Tasneem Khambaty, PhD
PRINCIPAL_INVESTIGATOR
University of Maryland, Baltimore County

Study Locations (Sites)

Baltimore VA Geriatric Research Education and Clinical Center (GRECC)
Baltimore, Maryland, 21201
United States

Collaborators and Investigators

Sponsor: University of Maryland, Baltimore

  • Tasneem Khambaty, PhD, PRINCIPAL_INVESTIGATOR, University of Maryland, Baltimore County

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-01
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2022-03-01
Study Completion Date2024-12-31

Terms related to this study

Keywords Provided by Researchers

  • Glucose Variability
  • Continuous Glucose Monitoring System (CGMS)
  • Prediabetes
  • Aging
  • Physical Functioning
  • Neurocognition
  • Cognitive Decline

Additional Relevant MeSH Terms

  • Glucose Metabolism Disorders (Including Diabetes Mellitus)
  • Cognitive Decline
  • Functional Status
  • PreDiabetes
  • Aging
  • Depression